What is happening. Isoniazid carries a recognized risk of hepatotoxicity. Silymarin from milk thistle has been studied as a hepatoprotective adjunct in patients on antitubercular therapy, with some trials suggesting it may reduce markers of liver injury. Evidence is mixed and milk thistle is not a substitute for standard liver monitoring.
Mechanism. Silymarin acts as an antioxidant and free-radical scavenger, may stabilize hepatocyte membranes, and supports glutathione status, which could mitigate oxidative hepatocellular stress associated with isoniazid metabolism.
Recommendation. Milk thistle is not a replacement for routine liver function monitoring during isoniazid therapy. If considering it as a hepatoprotective adjunct, discuss with a clinician. Continue scheduled liver enzyme checks and report symptoms such as nausea, dark urine, jaundice, or right upper abdominal pain promptly.